{"transactions":[{"id":1044135,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":53958,"kind":"person","name":"Zook Anthony P.","position":1,"cik":"0001582393","reported_name":"Zook Anthony P.","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T21:00:51.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":109847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025."}],"balance_after":109847,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":109847},"source":{"system":"sec-edgar","filing":"0001213900-25-086588","document":"marketforms-70725.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086588/marketforms-70725.xml","form_type":"4"}},{"id":1044134,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":75589,"kind":"person","name":"Riehle J Nick","position":1,"cik":"0001316746","reported_name":"Riehle J Nick","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T21:00:41.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":109847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025."}],"balance_after":109847,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":109847},"source":{"system":"sec-edgar","filing":"0001213900-25-086586","document":"marketforms-70726.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086586/marketforms-70726.xml","form_type":"4"}},{"id":1044133,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":75588,"kind":"person","name":"Gallagher Patrick Joseph","position":1,"cik":"0001648003","reported_name":"Gallagher Patrick Joseph","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T21:00:28.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":109847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025."}],"balance_after":109847,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":109847},"source":{"system":"sec-edgar","filing":"0001213900-25-086585","document":"marketforms-70723.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086585/marketforms-70723.xml","form_type":"4"}},{"id":1044131,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":75586,"kind":"person","name":"Roberts Michael J","position":1,"cik":"0001481629","reported_name":"Roberts Michael J","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"President and CEO"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T20:59:57.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":439386,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025."}],"balance_after":439386,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":439386},"source":{"system":"sec-edgar","filing":"0001213900-25-086583","document":"marketforms-70707.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086583/marketforms-70707.xml","form_type":"4"}},{"id":1044132,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":75587,"kind":"person","name":"Pedder Simon","position":1,"cik":"0001316736","reported_name":"Pedder Simon","relationship":{"director":true,"officer":true,"ten_percent_owner":true,"other":false,"officer_title":"Executive Chairman"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T20:59:40.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":192231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025."}],"balance_after":192231,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":192231},"source":{"system":"sec-edgar","filing":"0001213900-25-086582","document":"marketforms-70720.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086582/marketforms-70720.xml","form_type":"4"}},{"id":1044130,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":75585,"kind":"person","name":"Maness Timothy","position":1,"cik":"0001774294","reported_name":"Maness Timothy","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Financial Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T20:59:23.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":192231,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50% of the stock option vested on September 8, 2025. The remaining 50% of the stock option vests in equal monthly installments on the last day of each calendar month over 48 months, beginning on September 8, 2025."}],"balance_after":192231,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":192231},"source":{"system":"sec-edgar","filing":"0001213900-25-086581","document":"marketforms-70721.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086581/marketforms-70721.xml","form_type":"4"}},{"id":1044128,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":75584,"kind":"person","name":"Hewitt L Arthur","position":1,"cik":"0001316983","reported_name":"Hewitt L Arthur","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Development Officer"}}],"security":"Stock Option (right to buy)","published_at":"2025-09-10T20:59:01.000Z","date":"2025-09-08","kind":"grant","planned":false,"acquired":true,"shares":109847,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The stock option vests in equal monthly installments on the last day of each calendar month over 48 months beginning on September 8, 2025."}],"balance_after":109847,"derivative":{"exercise_price":4.4,"expiration_date":"2035-09-07","underlying":"Common Stock","underlying_shares":109847},"source":{"system":"sec-edgar","filing":"0001213900-25-086580","document":"marketforms-70722.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1938571/000121390025086580/marketforms-70722.xml","form_type":"4"}},{"id":1269883,"issuer":{"id":9083,"kind":"organization","name":"ADAPTIN BIO, INC."},"owners":[{"id":74656,"kind":"organization","name":"Lucius Partners LLC","position":1,"cik":"0002002106","reported_name":"Lucius Partners LLC","relationship":{"director":false,"officer":false,"ten_percent_owner":true,"other":false}}],"security":"Common Stock","published_at":"2025-02-13T21:50:03.000Z","date":"2025-02-11","kind":"other","planned":false,"acquired":false,"shares":1750000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of February 11, 2025, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 1,750,000 shares of Issuer's common stock prior to the consummation of the Merger on February 11, 2025. Matthew Eitner has the power to vote and to dispose of the shares held by Lucius Partners LLC and may be deemed the beneficial owner of the shares."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of February 11, 2025, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 1,750,000 shares of Issuer's common stock prior to the consummation of the Merger on February 11, 2025. Matthew Eitner has the power to vote and to dispose of the shares held by Lucius Partners LLC and may be deemed the beneficial owner of the shares."},{"field":"ownership.direct","element":"directOrIndirectOwnership","label":"F1","text":"As a condition under the terms of an Agreement and Plan of Merger and Reorganization, dated as of February 11, 2025, and pursuant to the terms of a stock cancellation agreement, the reporting person voluntarily surrendered and cancelled for no consideration 1,750,000 shares of Issuer's common stock prior to the consummation of the Merger on February 11, 2025. Matthew Eitner has the power to vote and to dispose of the shares held by Lucius Partners LLC and may be deemed the beneficial owner of the shares."}],"balance_after":3250000,"source":{"system":"sec-edgar","filing":"0001213900-25-013732","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/2002106/000121390025013732/ownership.xml","form_type":"4"}}]}